文献速递传染病防控与疫情报告免疫规划

美国呼吸道合胞病毒季节性特征,2017—2023年

Seasonality of Respiratory Syncytial Virus - United States, 2017-2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-04-07

分析2017年7月至2023年2月美国国家呼吸道与肠道病毒监测系统(NREVSS)的PCR检测结果,以阳性率≥3%的周定义为流行季。疫情前流行季10月开始、12月达峰、4月结束;2020—21年冬季流行未出现;2021—22季5月开始、7月达峰、次年1月结束;2022—23季6月开始、11月达峰。流行均先发于佛罗里达州和东南部,北部和西部较晚。

要点

  • 疫情前(2017—2020)流行季10月开始、12月达峰、4月结束。
  • 2020—21年典型冬季流行未出现;2021—22季5月开始、7月达峰、次年1月结束。
  • 2022—23季6月开始、11月达峰,晚于2021—22季但早于疫情前流行季。

核心结论

  • 2022—23季的时间提示季节性模式正向疫情前年份观察到的模式回归,但临床医生应意识到非流行季的RSV传播可能持续。
  • 持续监测RSV传播可指导RSV免疫预防以及临床试验和上市后有效性研究的时间安排。

研究设计与样本

  • 对2017年7月至2023年2月报告至国家呼吸道与肠道病毒监测系统(NREVSS)的聚合酶链反应(PCR)检测结果进行分析。
  • 将RSV PCR检测阳性率≥3%的周定义为季节性RSV流行。

主要发现

  • 全国疫情前流行季(2017—2020)10月开始、12月达峰、4月结束。
  • 2020—21年典型的冬季RSV流行未发生。
  • 2021—22季5月开始、7月达峰、次年1月结束。
  • 2022—23季6月开始、11月达峰,晚于2021—22季但早于疫情前流行季。
  • 疫情前和疫情期间,流行均先在佛罗里达州和东南部开始,在更靠北和西部的地区开始较晚。

关键数值与推荐

  • 季节性RSV流行定义为RSV PCR检测阳性率≥3%的周。
  • 美国RSV感染每年估计导致5岁以下儿童58 000—80 000例住院、65岁及以上成人60 000—160 000例住院。

临床怎么用

  • 临床医生应意识到非流行季RSV传播可能持续。
  • 持续监测RSV传播可指导RSV免疫预防以及临床试验和上市后有效性研究的时间安排。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the United States, respiratory syncytial virus (RSV) infections cause an estimated 58,000-80,000 hospitalizations among children aged <5 years (1,2) and 60,000-160,000 hospitalizations among adults aged ≥65 years each year (3-5). U.S. RSV epidemics typically follow seasonal patterns, peaking in December or January (6,7), but the COVID-19 pandemic disrupted RSV seasonality during 2020-2022 (8). To describe U.S. RSV seasonality during prepandemic and pandemic periods, polymerase chain reaction (PCR) test results reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS)* during July 2017-February 2023 were analyzed. Seasonal RSV epidemics were defined as the weeks during which the percentage of PCR test results that were positive for RSV was ≥3% (9). Nationally, prepandemic seasons (2017-2020) began in October, peaked in December, and ended in April. During 2020-21, the typical winter RSV epidemic did not occur. The 2021-22 season began in May, peaked in July, and ended in January. The 2022-23 season started (June) and peaked (November) later than the 2021-22 season, but earlier than prepandemic seasons. In both prepandemic and pandemic periods, epidemics began earlier in Florida and the Southeast and later in regions further north and west. With several RSV prevention products in development,† ongoing monitoring of RSV circulation can guide the timing of RSV immunoprophylaxis and of clinical trials and postlicensure effectiveness studies. Although the timing of the 2022-23 season suggests that seasonal patterns are returning toward those observed in prepandemic years, clinicians should be aware that off-season RSV circulation might continue.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Hamid S, Winn A, Parikh R, et al. Seasonality of Respiratory Syncytial Virus - United States, 2017-2023. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37022977. doi:10.15585/mmwr.mm7214a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。